WALTHAM, Mass.–()– ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that David B. Johnston has stepped down as Chief Financial Officer of the Company, with immediate effect.
Name: David B. Johnston
Continent: North America
Company: ImmunoGen, Inc.
Announcement Date: November 25, 2018, 11:00pm
Resignation Date: November 25, 2018, 11:00pm